» Authors » Kyu Young Lee

Kyu Young Lee

Explore the profile of Kyu Young Lee including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 66
Citations 470
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee D, Baek J, Kim Y, Lee B, Cho E, Joo E, et al.
Asian J Psychiatr . 2024 Sep; 102:104203. PMID: 39293130
Although large-scale genome-wide association studies (GWASs) have revealed the genetic architecture of schizophrenia, these studies have mainly focused on populations of European ancestry. This study aimed to identify common genetic...
2.
Kim S, Jung D, Kim D, Lee J, Lee K, Won S, et al.
Psychiatry Investig . 2024 Aug; 21(7):762-771. PMID: 39089702
Objective: This study was performed to evaluate the efficacy and safety of lurasidone (160 mg/day) compared to quetiapine XR (QXR; 600 mg/day) in the treatment of acutely psychotic patients with...
3.
Jeong J, Kim S, Yu J, Won S, Lee S, Kim S, et al.
Schizophr Res . 2024 Jun; 270:304-316. PMID: 38944977
Though categorized as separate illnesses, schizophrenia and autism are known to exhibit shared characteristics. This study explored the distinctions in clinical, cognitive, and functional characteristics among individuals with recent-onset psychosis,...
4.
Shin D, Lee J, Kim Y, Park J, Shin D, Song Y, et al.
J Proteome Res . 2023 Dec; 23(1):329-343. PMID: 38063806
Psychiatric evaluation relies on subjective symptoms and behavioral observation, which sometimes leads to misdiagnosis. Despite previous efforts to utilize plasma proteins as objective markers, the depletion method is time-consuming. Therefore,...
5.
Rhee S, Shin D, Shin D, Song Y, Joo E, Jung H, et al.
Transl Psychiatry . 2023 Jun; 13(1):195. PMID: 37296094
The conventional differentiation of affective disorders into major depressive disorder (MDD) and bipolar disorder (BD) has insufficient biological evidence. Utilizing multiple proteins quantified in plasma may provide critical insight into...
6.
Moon S, Kim J, Kim D, Lee K, Reines E, Lee M, et al.
Front Psychiatry . 2023 Mar; 14:1075939. PMID: 36937717
Background: A post-marketing surveillance study was conducted to assess the real-world safety and effectiveness of vortioxetine for the treatment of major depressive disorder (MDD) in South Korea. Methods: Adult patients...
7.
Rhee S, Shin D, Shin D, Song Y, Joo E, Jung H, et al.
Transl Psychiatry . 2023 Feb; 13(1):44. PMID: 36746927
Data-driven approaches to subtype transdiagnostic samples are important for understanding heterogeneity within disorders and overlap between disorders. Thus, this study was conducted to determine whether plasma proteomics-based clustering could subtype...
8.
Li L, Rami F, Lee B, Kim W, Kang C, Kim S, et al.
Psychiatry Res . 2022 Dec; 320:115035. PMID: 36584504
To promote recovery in psychosis, targeting modifiable factors related to recovery is critical. Using more strict definition of full recovery, we examined predictors for recovery in patients with early stage...
9.
Kim K, Kim Y, Joo E, Kim E, Bhang S, Choi J, et al.
J Clin Psychopharmacol . 2022 Nov; 42(6):536-543. PMID: 36356202
Background: Corrected QT-interval (QTc) prolongation (QTP) is a rare but fatal adverse effect of antipsychotics. Clozapine is the only antipsychotic recommended for treatment of resistant schizophrenia; however, clozapine has been...
10.
Li L, Rami F, Lee B, Kim W, Kim S, Lee B, et al.
Schizophrenia (Heidelb) . 2022 Oct; 8(1):87. PMID: 36302861
In the present study, various outcomes over 3-year period in patients with early stage psychosis including remission, recovery, relapse and medication adherence were investigated. Predictor for full recovery at year...